Vadalentamig is a human-derived bispecific antibody targeting NKG2D/CD314 & ERBB1/EGFR/HER1 [1].
References:
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 39, No. 4, 2025
References:
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 39, No. 4, 2025
















